Article thumbnail

No association of factor XIII Val34Leu polymorphism with primary intracerebral hemorrhage and healthy controls in Korean population.

By Ki-Hyun Cho, Byeong-Chae Kim, Myeong-Kyu Kim and Boo-Ahn Shin

Abstract

The polymorphism in the factor XIII A-subunit gene (FXIII Val34Leu) has been recognized as a risk factor for primary intracerebral hemorrhage (PICH). In addition, FXIII Val34Leu has a significant ethnic heterogeneity. FXIII Val34Leu was detected in 41.7-54.8% of the Westerners, but in 2.5% of the Asians. We aimed to evaluate the prevalence of FXIII Val34Leu in patients with PICH and in healthy controls among Koreans. We recruited 58 in-patients with PICH, defined by brain computed tomography or magnetic resonance imaging, and 48 controls matched for age, sex, and risk factors for cerebrovascular diseases. Genomic DNA was extracted from blood. A 183-bp fragment of exon 2/intron B of the factor XIII Asubunit gene was amplified by polymerase chain reaction (PCR). The factor XIII genotype was determined through a single-stranded conformational polymorphism. Fifty-eight patients and 48 controls showed the same band patterns on SSCP. In addition, we directly sequenced six random-selected DNA segments using DNA auto-sequencer. In conclusion, the results of this study suggest that FXIII Val34Leu be absent or rare both in patients with PICH and in healthy controls among Koreans

Topics: Research Article
Publisher: Korean Academy of Medical Sciences
OAI identifier: oai:pubmedcentral.nih.gov:3054847
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1998). A common coding polymorphism in the FXIII A-subunit gene (FXIII Val34Leu) affects cross-linking activity. Thromb Haemostasis
  2. (2001). A common mutation in the gene for coagulation factor XIII-A (Val34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
  3. (1985). An extended survey of the genetic polymorphism at the human coagulation factor XIIIA subunit structural locus. Hum Hered
  4. (1998). Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost
  5. (1999). Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood
  6. (1999). Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males. Atherosclerosis
  7. (1998). b-chains prevent the proteolytic inactivation of the a-chains of plasma factor XIII. Biochim Biophys Acta
  8. (1988). Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor.
  9. (1994). Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood
  10. (1992). Deficiency of coagulation factor XIII A subunit caused by the dinucleotide deletion at the 5′ end of exon III.
  11. (1989). Electron microscopy and hydrodynamic properties of factor XIII subunits.
  12. (2000). Examining thrombin hydrolysis of the factor XIII activation peptide leads to a proposal for explaining the cardio-protective effects observed with the factor XIII Val34Leu mutation.
  13. (1993). Factor XIII ABristol 1: detection of a nonsense mutation (Arg171→stop codon) in factor XIII A subunit defi-Factor XIII Val34Leu Polymorphism 253 ciency.
  14. (1998). Factor XIII Val 34 Leu; a novel association with primary intracerebral hemorrhage. Stroke
  15. (2000). Factor XIII Val34Leu and the risk of myocardial infarction. Haematologica
  16. (1999). Factor XIII Val34Leu is a genetic factor involved in the aetiology of venous thrombosis. Thromb Haemost
  17. (1979). Genetic polymorphism of the A subunit of human coagulation factor XIII.
  18. (2000). Genetic polymorphisms and coronary artery disease in the south of France. Thromb Haemost
  19. (1986). Genetic studies of low abundance human plasma proteins. II. Population genetics of coagulation factor XIIIB.
  20. (1973). Human factor XIII from plasma and platelets: molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin.
  21. (1992). Identification of a point mutation in factor XIII A subunit deficiency. Blood
  22. (1988). Localization of the coagulation factor XIII A subunit gene (F13A) to chromosome bands 6p24-p25. Cytogenet Cell Genet
  23. (1989). Localization of the coagulation factor XIII B subunit gene (F13B) to chromosome bands 1q31-32.1 and restriction fragment length polymorphism at the locus. Hum Genet
  24. (1987). Localization of the gene for coagulation factor XIII a-chain to chromosome 6 and identification of sites of synthesis.
  25. (1996). Novel polymorphisms and haplotypes in the human coagulation factor XIII A-subunit gene. Hum Genet
  26. (1998). Prevalence of FXIII V34L in populations with different cardiovascular risk. Thromb Haemost
  27. (2000). Prothrombin G20210A, Factor V Leiden, and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria. Thromb Res
  28. (1996). The ABCs of measuring intracerebral hemorrhage volumes. Stroke
  29. (2000). The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood
  30. (2000). The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood
  31. (2000). The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Haematologica
  32. (1998). The Val34Leu polymorphism in the A-subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. Blood
  33. (1991). Transglutaminase: multifunctional crosslinking enzymes that stabilize tissues.
  34. (1993). Two genetic defects in a patient with complete deficiency of the b-subunit for coagulation factor XIII. Blood